NDC product
Aquanaz
NDC 29978-587 · Capital Pharmaceutical, LLC
Key facts
| Product NDC | 29978-587 |
|---|---|
| Proprietary name | Aquanaz |
| Nonproprietary name | Dextromethorphan Hydrobromide, Guaifenesin and Phenylephrine Hydrochloride |
| Substances | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Capital Pharmaceutical, LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA] and 3 more |
| Marketing start | Mar 10, 2015 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: